AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Michael Pollan and Xand Van Tulleken on the Science of Psychedelics
Intelligence Squared
Challenges and Risks in Psychedelic Drug Research
The pharmaceutical industry is primarily interested in buying out small companies that find ways to profit from psychedelic drugs. They don't invest in researching psychiatric drugs. There are concerns about negative media stories affecting the progress of psychedelic drug research, such as cases of suicide or sexual abuse. Additionally, there's a fear of a political backlash and the negative association of suicide with psychedelic drugs, even though similar risks exist with traditional SSRIs.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode